An Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of LOU064 in Subjects With CSU

Completed · Phase 2

Conditions studied: Chronic Spontaneous Urticaria

In brief

The main objective to assess the long-term safety and tolerability of LOU064 in patients with chronic spontaneous urticaria (CSU) who have participated in study CLOU064A2201 (NCT03926611)

Key facts

Study ID

NCT04109313

Run by

Novartis Pharmaceuticals

People needed

229

Starts

2019-10-24

Expected to finish

2022-09-09

Last updated by the study team

2024-06-20

Who can join

Age: 18 and older, up to 99. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Novartis Investigative Site — Little Rock, Arkansas, United States
• Novartis Investigative Site — Mission Viejo, California, United States
• Novartis Investigative Site — San Diego, California, United States
• Novartis Investigative Site — Walnut Creek, California, United States
• Novartis Investigative Site — Pembroke Pines, Florida, United States
• Novartis Investigative Site — Owensboro, Kentucky, United States
• Novartis Investigative Site — Ypsilanti, Michigan, United States
• Novartis Investigative Site — St Louis, Missouri, United States
• Novartis Investigative Site — Grove City, Ohio, United States
• Novartis Investigative Site — CABA, Buenos Aires, Argentina
• Novartis Investigative Site — La Plata, Buenos Aires, Argentina
• Novartis Investigative Site — Mendoza, Mendoza Province, Argentina
• Novartis Investigative Site — CABA, Argentina
• Novartis Investigative Site — Edegem, Antwerpen, Belgium
• Novartis Investigative Site — Liège, Belgium
• Novartis Investigative Site — Edmonton, Alberta, Canada
• Novartis Investigative Site — London, Ontario, Canada
• Novartis Investigative Site — Niagara Falls, Ontario, Canada
• Novartis Investigative Site — Ottawa, Ontario, Canada
• Novartis Investigative Site — Québec, Quebec, Canada
• Novartis Investigative Site — Verdun, Quebec, Canada
• Novartis Investigative Site — Prague, Czech Republic, Czechia
• Novartis Investigative Site — Prague, Prague 1, Czechia
• Novartis Investigative Site — Tábor, Czechia
• Novartis Investigative Site — Litchfield Park, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.